Thomas Hallam serves as Executive at PALISADE BIO, INC., where they oversee executive responsibilities. Since joining the company, Thomas Hallam has executed 4 insider transactions totaling $36.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 16, 2022 involved purchasing 40,000 shares valued at $10.0K.
Thomas Hallam currently holds 57,592 shares of PALISADE BIO, INC. (PALI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Hallam has been a net buyer of PALI stock. They have purchased $36.7K and sold $0 worth of shares.
Thomas Hallam's most recent insider trade was on Aug 16, 2022, when they purchased 40,000 shares at $0.25 per share.
Get notified when new Form 4 filings are submitted
| $1.18 |
| Discretionary |
| Sep 21, 2021 | PALI | $14.9K | Purchase | 6,000 | $2.49 | Discretionary |
| Apr 27, 2021 | PALI | $0 | Award | 1,592 | $N/A | Discretionary |